semaglutide mce Ozempic® Semaglutide 0.25 mg -

This phase also investigates long-term benefits, focusing on reducing cardiovascular risk and improving liver function in patients with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)

In hypoglycemia, GLP-1 reduces the brain glucose concentration

During periods of significant illness or dehydration, patients should seek medical advice and may need to temporarily interrupt treatment

Nausea is a common side effect of Tirzepatide, but it often improves after adjusting the dose

Now recognised as an epidemic, there is increasing pressure on hospitals and clinics, as the centre of care, to treat obesity and other related diseases medically. ADDRESSING THE BURDEN OF OBESITY AND OTHER METABOLIC DISEASES The pervasiveness of obesity continues to be staggering

The most crucial part of aftercare involves regular monitoring, committing to a healthy diet, and increasing physical activity to help burn calories